Jung-Mi Hah, Ph.D.
Affiliations: | 2002 | Northwestern University, Evanston, IL |
Area:
Organic, Synthetic, Bio-Organic, Medicinal Chemistry, Chemical BiologyGoogle:
"Jung-Mi Hah"Mean distance: 9.2 | S | N | B | C | P |
Parents
Sign in to add mentor| Richard B. Silverman | grad student | 2002 | Northwestern | |
| (L-arginine analogues as probes for the mechanistic study of nitric oxide synthase and peptidomimetic approach for the development of potent and selective inhibitors of neuronal nitric oxide synthase.) | ||||
| David S. Lawrence | grad student | 2005 | Albert Einstein College of Medicine of Yeshiva University | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bhujbal SP, Jun J, Park H, et al. (2024) Gaining Insights into Key Structural Hotspots within the Allosteric Binding Pockets of Protein Kinases. International Journal of Molecular Sciences. 25 |
| Baek J, Jun J, Kim H, et al. (2024) Targeting the CSF-1/CSF-1R Axis: Exploring the Potential of CSF1R Inhibitors in Neurodegenerative Diseases. Journal of Medicinal Chemistry |
| Jun J, Baek J, Kang D, et al. (2022) Novel 1,4,5,6-tetrahydrocyclopenta[d]imidazole-5-carboxamide-based JNK3 inhibitors: Design, synthesis, molecular docking, and therapeutic potential in neurodegenerative diseases. European Journal of Medicinal Chemistry. 245: 114917 |
| Jun J, Yang S, Lee J, et al. (2022) Discovery of novel imidazole chemotypes as isoform-selective JNK3 inhibitors for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 245: 114894 |
| Bhujbal SP, Kim H, Bae H, et al. (2022) Design and Synthesis of Aminopyrimidinyl Pyrazole Analogs as PLK1 Inhibitors Using Hybrid 3D-QSAR and Molecular Docking. Pharmaceuticals (Basel, Switzerland). 15 |
| Bhujbal SP, He W, Hah JM. (2022) Design of Novel IRAK4 Inhibitors Using Molecular Docking, Dynamics Simulation and 3D-QSAR Studies. Molecules (Basel, Switzerland). 27 |
| Im D, Jun J, Baek J, et al. (2022) Rational design and synthesis of 2-(1-indazol-6-yl)-1-benzo[d]imidazole derivatives as inhibitors targeting FMS-like tyrosine kinase 3 (FLT3) and its mutants. Journal of Enzyme Inhibition and Medicinal Chemistry. 37: 472-486 |
| Jun J, Baek J, Yang S, et al. (2021) Discovery of a Potent and Selective JNK3 Inhibitor with Neuroprotective Effect Against Amyloid β-Induced Neurotoxicity in Primary Rat Neurons. International Journal of Molecular Sciences. 22 |
| Cho H, Hah JM. (2021) A Perspective on the Development of c-Jun N-terminal Kinase Inhibitors as Therapeutics for Alzheimer's Disease: Investigating Structure through Docking Studies. Biomedicines. 9 |
| Oh Y, Jung H, Kim H, et al. (2021) Design and Synthesis of a Novel PLK1 Inhibitor Scaffold Using a Hybridized 3D-QSAR Model. International Journal of Molecular Sciences. 22 |